SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+16.8%
5Y CAGR+19.0%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+16.8%/yr
vs +40.1%/yr prior
5Y CAGR
+19.0%/yr
Consistent
Acceleration
-23.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $119.44B | +20.2% |
| 2024 | $99.33B | +245.7% |
| 2023 | $28.74B | -61.6% |
| 2022 | $74.89B | +49.8% |
| 2021 | $50.00B | -0.2% |
| 2020 | $50.13B | +593.2% |
| 2019 | $-10.16B | -152.2% |
| 2018 | $19.46B | -42.6% |
| 2017 | $33.89B | +0.1% |
| 2016 | $33.87B | - |